XNAS · INBS
-1.26% · -$0.0200 · Vol 17.4K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Intelligent Bio Solutions Inc. Common Stock

Intelligent Bio Solutions Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$1.57
Card
Relationship Map

Follow $INBS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $INBS by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
INBS
Intelligent Bio Solutions Inc. Common Stock
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

42/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INBS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INBS catalysts
About Intelligent Bio Solutions Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2020
Employees
60
Country
US

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.59
Day high
$1.64
Day low
$1.55
Previous close
$1.59
52W high
$17.92
-91.24% from high
52W low
$1.55
0% of range
Market cap
$5.3M
Beta
0.27
Shares out
3.3M
Volume
17.4K
0.08× rel vol
Avg volume
217.8K
VWAP
$1.59
Price history computed in-house
1W
-5.42%
1M
-29.91%
3M
-27.31%
1Y
-86.11%
YTD
-83.53%
SMA 50 $2.11 · below
SMA 200 $3.85 · below
52W position 0%

INBS overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading INBS Form 4 filings
Public disclosures

Congress activity in INBS

No receipt-qualified filings found.

Federal contracts

INBS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INBS in this window.
Lobbying spend

INBS lobbying filings, year to date.

Registered lobbying filings matched to Intelligent Bio Solutions Inc. Common Stock.

$2.0M
Refresh interval: 12hSource: LDA disclosure filings
Budget/Appropriations Manufacturing Science/Technology Taxation/Internal Revenue Code Foreign Relations Environment/Superfund Trade (domestic/foreign) Education Economics/Economic Development Government Issues Defense Telecommunications Labor Issues/Antitrust/Workplace Immigration Copyright/Patent/TrademarkBudget/Appropriations Defense Manufacturing Science/Technology Trade (domestic/foreign)Budget/Appropriations Defense Manufacturing Science/Technology Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
Filing
$700.0K
INTEL CORPORATION

INTEL CORPORATION

Jul 17, 2026
Filing
$680.0K
INTEL CORPORATION

INTEL CORPORATION

Apr 20, 2026
Filing
$490.0K
INTEL CORPORATION

INTEL CORPORATION

Jan 20, 2026
Loading news for INBS
Analyst ratings
Sovereign unlock shows live analyst consensus for INBS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.